MEGAN KELLAR: Open Payments
NPI 1215596168 · SHERWOOD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 48 payments from 11 companies in 2025. Trend: 2023 $1,441 · 2024 $2,665 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $345 |
| Insulet Corporation | 7 | $141 |
| Novo Nordisk Inc | 11 | $138 |
| Lilly USA, LLC | 5 | $98 |
| Dexcom, Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
| Abbott Laboratories | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
Products named: MINIMED 780G, Omnipod, Ozempic, MOUNJARO, Dexcom G6 Transmitter, Kerendia, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3.
Industry payments across AR — which companies pay providers there.
